<DOC>
	<DOCNO>NCT03070678</DOCNO>
	<brief_summary>Primary Objective : To assess effect multiple dose mefenamic acid pharmacokinetics ( PK ) sotagliflozin metabolite healthy male female subject . Secondary Objectives : - To assess total 24 hour urinary glucose excretion ( UGE ) 400 mg sotagliflozin alone combination mefenamic acid healthy male female subject . - To assess safety tolerability sotagliflozin alone combination mefenamic acid healthy male female subject .</brief_summary>
	<brief_title>Interaction Study Evaluate Effects Mefenamic Acid Pharmacokinetics Pharmacodynamics Sotagliflozin Healthy Male Female Subjects</brief_title>
	<detailed_description>The expect duration study approximately 59 day per subject , include 2-28 day screen , treatment period 1 7 day , treatment period 2 8 day , least 7 day wash-out period , end study visit , 14-21 day last dose sotagliflozin .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Mefenamic Acid</mesh_term>
	<criteria>Inclusion criterion : Healthy male female subject , 18 55 year age , inclusive . Body weight 50.0 100.0 kg , inclusive , male , 40.0 90.0 kg , inclusive , female . Certified healthy comprehensive clinical assessment ( detailed medical history complete physical examination ) . Normal vital sign , ECG , laboratory parameter , aPTT ( activate partial thromboplastin time ) exceed normal control 10 second . Female subject must use double contraception method include highly effective method birth control except undergone sterilization least 3 month earlier postmenopausal . Having give write informed consent prior undertake studyrelated procedure . Covered health insurance system applicable , and/or compliance recommendation national law force relate biomedical research . Not administrative legal supervision . Exclusion criterion : Any history presence clinically relevant disease screening , could interfere objective study safety subject 's participation . Frequent headache and/or migraine , recurrent nausea and/or vomit ( twice month ) . Blood donation , volume , within 2 month inclusion . Symptomatic postural hypotension , irrespective decrease blood pressure , asymptomatic postural hypotension define decrease systolic blood pressure ≥20 mmHg within 3 minute change supine stand position . History presence drug alcohol abuse . Smoking 5 cigarette equivalent per day , unable stop smoking study . Excessive consumption beverage contain xanthine base ( 4 cup glass per day ) . If female , pregnancy ( define positive βHCG ( human chorionic gonadotropin ) blood test applicable ) , breastfeed . Any medication ( include St John 's Wort ) within 14 day inclusion within 5 time elimination halflife pharmacodynamic halflife medication ; vaccination within last 28 day biologics ( antibody derivative ) give within 4 month inclusion . Any oral contraceptive screen period least 15 day prior inclusion ; injectable contraceptive hormonal intrauterine device within 12 month prior inclusion ; topical control delivery contraceptive ( patch ) 3 month prior inclusion . Any subject exclusion period previous study accord applicable regulation . Any subject contact case emergency . Any subject Investigator subinvestigator , research assistant , pharmacist , study coordinator , staff thereof , directly involve conducting study . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>